1.1.1.1.1.2
2.2.1 完全缓解（CR） 所有非靶病灶消失和肿瘤标志物恢
复正常。
2.2.2 未完全缓解/稳定（IR/SD） 存在一个或多个非靶病
灶和/或肿瘤标志物持续高于正常值。
2.2.3 病变进展（PD） 出现一个或多个新病灶和/或已有的
非靶病灶明确进展。 2.3 最佳总疗效的评价
最佳总疗效的评价是指从治疗开始到疾病进展或复发之间
所测量到的最小值。通常，病人最好疗效的分类由病灶测量和确认组成。
25
1.1.1.1.1.2
参考文献
1、Ajani JA, Bekaii-Saab T, Yang G, et al. NCCN clinical practice guidelines in oncology:gastric cancer. 2009.
2、Karam SM. Cellular origin of gastric cancer. Ann N Y Aced Sci, 2008, 1138:162-168
3、Hamashima C , Shibuya D , Yamazaki H , et al. The Japaneseguidelines for gastric cancer screening. Jpn 1 Clin Oncol, 2008, 38(4):259-267.
4、Leung WK, Wu MS, Kakugawa Y, et al. Asia Pacific WorkingGroup on Gastric Cancer. Screening for gastric cancer in Asia: current evidence and practice. Lancet Oncol, 2008, 9(3):279-287.
5、朱正纲，严超，陈克敏，等。内镜超声检查与多层螺旋CT对胃癌术前分期的对比研究.中华胃肠外科杂志，2002, 5(2):99-103
6、Jatzko GR, Lisborg PH, Denk H, et al. A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan. Cancer, 1995，76(8):1302-1312.
7、Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005, 55: 74-108
26
1.1.1.1.1.2
8、Sierra A , Regueira FM，Hernlx}ndez-LiwGin JL, et al. Role of the extended lymphadenectomy in gastric cancer surgery: experience in a single institution. Ann Surg Oncol, 2003 , 10( 3 ): 219-226.
9、董志伟，谷铣之. 临床肿瘤学. 北京：人民卫生出版社，2002：9-27.
10、Enzinger PC, Benedetti JK, Meyerhardt JA, et al. Impact of hospital volume on recurrence and survival after surgery for gastnc cancer.2007，245(3):426-434.
11、MacDonald, JS, Smalley SR, Benedetti J, et al. Chemoradio-therapy after surgery compared with surgery alone
for
adeno-carcinoma
of
the
stomach
or
gastroesophageal junction. N Engl JMed , 2001, 345:725-730.
12、Smalley SR, Gunderson L, Tepper JE，et al. Gastric surgical adjuvant radiotherapy consensus report-rationale and treatment implementation. Int J [}adiat Oncol Biol Phys, 2002,52:283-293.
13、孙燕主编. 抗肿瘤药物手册. 人民卫生出版社. 2007:32-35.
14、Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual, 6th ed. New York: Springer-Verlag, 2002.
27
1.1.1.1.1.2
Roder RD, Bottcher K, Busch R, et al. Classification o# regional lymph node metastases from gastric carcinoma. Cancer, 1998;82:621-631.
15、Brennan MF.lymph node dissection for gastric cancer. N Engl J Med , 1999 , 340:956-958
16、Schwars RE, Lagala-Nevarez K. Recurrence patterns after radical gastrectomy for gastric cancer. Prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol, 2002,9: 294-400.
28